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Introduction and Aims: Attaining dry body weight is paramount in dialysis practice,
but this goal is not always reached. We hypothesized that the amount of end-dialysis
overweight (edOW), could be associated to increased chronic inflammation and
mortality. Aim of the study: to evaluate the effect of edOWon serum C-reattive protein
(hsCRP) concentrations and on survival in a cohort of 182 prevalent HD patients (pts)
followed for 36 months.
Methods: In 182 pts (117 men, age 65±12 years, vintage 48 months; range 6-336),
edOW was present in 98/182 (54%) pts. Mean value was 0.4±0.2 Kg (range: 0.1-1.4). In
the 98 pts with edOW (Group 1) and in the other 84 (Group 2) we evaluated:
Ultrafiltration rate(UFR), hsCRPdry body weight (dBW), Kt/V, protein catabolic rate
(PCRn), interdialytic weight gain (IDWG), mean arterial pressure (MAP). Unpaired
Student’s t test was employed to compare groups, linear regression analysis to test
correlations, log-rank test and Kaplan-Meier curves to evaluate survival.
Results:Mean UFR was 11.7±2.8 ml/Kg/hour, dBW 64±12 Kg, hsCRP 6.6 (0.2-36)
mg/L, Kt/V 1.27±0.09, PCRn 1.06±0.10 g/Kg/day, IDWG 2.8±0.4 Kg, MAP 97±6.5
mmHg. edOW and hsCRP were directly and significantly correlated (r= 0.67;
p<0.0001). Comparison between pts with (Group 1) and without (Group 2) edOW
showed significant differences in: UFR (12.7±2.6 vs 10.9±2.6 ml/Kg/hour; p< 0.0001),
hsCRP (13.0±8.1 vs 5.2±5.3 mg/L; p< 0.0001), and PCRn (1.03±0.09 vs 1.08±0.10 g/
Kg/day; p<0.004). 98 pts (54%) died during follow-up for cardiovascular complications
in 69% of cases. Survival curves showed significantly greater mortality in Group 1 vs
Group 2 in relation to the amount of edOW, and hsCRP (p<0.0001).
Conclusions: edOW and chronic inflammation are directly correlated in HD pts, and
both are associated to a greater long-term risk of mortality.
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